NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44)

Jurisdiction:
Federal
Incentive Type: Grant Program
Industries:
Medical, Research, Health And Safety
Eligible Sector:
Business
Category:
Financial Incentive
Time Period:
FY 2015
Governing Body: National Institutes of Health
What’s it worth?: Not mentioned

The NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement funding opportunity was developed to provide funds for the implementation of investigator-initiated clinical trials. The program prioritized high-risk clinical trials. Funds may be used for:

  • Training of study personnel
  • Enrollment and recruitment of study subjects
  • Investigational product cost
  • Data collection, management, and quality control
  • Laboratory work and data analysis
  • Study management and oversight
  • Establishment of committees to manage the complexity of the trial
  • Preparation of the final study report
  • Other pre-approved activities

Typical award amounts of not more than $225,000 for Phase I projects and up to $1,500,000 for Phase II projects with project duration of up to three years. All applicants must meet the following criteria.